About HotSpot Therapeutics
HotSpot Therapeutics is a company based in Boston (United States) founded in 2017. HotSpot Therapeutics has raised $210 million across 3 funding rounds from investors including Atlas Venture, Revelation Partners and Life Sciences Partners. The company has 37 employees as of December 31, 2022. HotSpot Therapeutics offers products and services including Smart Allostery™ Platform. HotSpot Therapeutics operates in a competitive market with competitors including Insitro, TOLREMO therapeutics, Certara, Inpharmatica and CytoReason, among others.
- Headquarter Boston, United States
- Employees 37 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hotspot Therapeutics Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$210 M (USD)
in 3 rounds
-
Latest Funding Round
$100 M (USD), Series C
Nov 29, 2021
-
Investors
Atlas Venture
& 13 more
-
Employee Count
37
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HotSpot Therapeutics
HotSpot Therapeutics offers a comprehensive portfolio of products and services, including Smart Allostery™ Platform.
Integrates AI, pharmacology, and chemistry for allosteric medicine development.
People of HotSpot Therapeutics
Unlock access to complete
Unlock access to complete
Funding Insights of HotSpot Therapeutics
HotSpot Therapeutics has successfully raised a total of $210M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $100 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in HotSpot Therapeutics
HotSpot Therapeutics has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include Atlas Venture, Revelation Partners and Life Sciences Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life science and biotechnology sectors
|
Locked | Locked | Locked | |
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Locked | Locked | Locked | |
|
Private equity investments in life sciences businesses are managed.
|
Locked | Locked | Locked |
Investor details for HotSpot Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HotSpot Therapeutics
Investment portfolio details for HotSpot Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HotSpot Therapeutics
Detailed financials for HotSpot Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hotspot Therapeutics Comparisons
Peer comparison for HotSpot Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HotSpot Therapeutics
HotSpot Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, TOLREMO therapeutics, Certara, Inpharmatica and CytoReason, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Anti-cancer small molecules are developed to target drug resistance pathways.
|
|
| Locked | Locked | Locked |
Provider of a platform for in silico drug discovery and consulting services
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
|
| Locked | Locked | Locked |
Immune system-based drugs are discovered via biological data analytics.
|
Detailed competitors of HotSpot Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hotspot Therapeutics
Complete news archive for HotSpot Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HotSpot Therapeutics
HotSpot Therapeutics was founded in 2017 and raised its 1st funding round 1 year after it was founded.
HotSpot Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
HotSpot Therapeutics is a funded company, having raised a total of $210M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at HotSpot Therapeutics is 37.
HotSpot Therapeutics offers a proprietary platform for protein structure-function analysis. The company has developed the proprietary technology platform used to analyze the allosteric druggable sites on the regulatory proteins required for its function using novel compounds.
HotSpot Therapeutics's top competitors include Insitro, Certara and GRO Biosciences.
HotSpot Therapeutics offers Smart Allostery™ Platform.
HotSpot Therapeutics has 14 investors. Key investors include Atlas Venture, Revelation Partners, Life Sciences Partners, Tekla Capital Management, and Monashee Investment Management.